NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Grey Matter Neurosciences

Grey Matter Neurosciences

Private
TorontoHealthcare & Life Scienceshttps://greymatterneurosciences.com/

Last Round

Seed

Dec 1, 2024

Total Funding Raised

$14M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Grey Matter Neurosciences is a medical technology company developing revolutionary medical devices and drug-device combinations to treat age-related diseases of the brain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Mental Health, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

transcranial focused ultrasoundtFUSneuromodulationfocused ultrasoundneurotechnologyAlzheimer's treatmentmedtechmedical devicebrain stimulationcognitive enhancementdementia treatmentultrasound headsetdeep brain stimulationclinical trialsdrug-device combination

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Grey Matter Neurosciences Comparables

Compare Grey Matter Neurosciences with similar companies based on industry and business-model similarity.

Grey Matter Neurosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceretas
86%
Attune Neurosciences
78%
NeuroEM Therapeutics
78%

Grey Matter Neurosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2024

Key People

Founding team and executive leadership

Jeffrey Coull

Founder And CEO

Founding Team

Grey Matter Neurosciences Investors

Notable investors and investment history

Grey Matter Neurosciences investors
InvestorRounds
Ontario Brain InstituteSeed
Wittington VenturesSeed
TIAPSeed
Weston Family FoundationSeed
Ontario Centre of InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Grew 19% QoQ, from 21 to 25 employees.

  • Apr 16, 2026

    Monthly visitors grew 133% MoM, reaching 1.8K.

Grey Matter Neurosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Grey Matter Neurosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Grey Matter Neurosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range26
Year Founded2024
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.